E

Euroapi SAS
PAR:EAPI

Watchlist Manager
Euroapi SAS
PAR:EAPI
Watchlist
Price: 3.22 EUR -0.68% Market Closed
Market Cap: 307.8m EUR

Relative Value

The Relative Value of one EAPI stock under the Base Case scenario is hidden EUR. Compared to the current market price of 3.22 EUR, Euroapi SAS is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EAPI Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
55
vs Industry
88
Median 3Y
0.4
Median 5Y
0.4
Industry
2.5
Forward
0.3
vs History
vs Industry
37
Median 3Y
-2.1
Median 5Y
-2.1
Industry
21.8
Forward
-15.7
vs History
60
vs Industry
52
Median 3Y
3.4
Median 5Y
3.3
Industry
16.6
vs History
vs Industry
25
Median 3Y
-2
Median 5Y
-4.8
Industry
24
vs History
70
vs Industry
79
Median 3Y
0.4
Median 5Y
0.4
Industry
2.1
vs History
62
vs Industry
89
Median 3Y
0.6
Median 5Y
0.5
Industry
2.7
Forward
0.3
vs History
62
vs Industry
73
Median 3Y
3.3
Median 5Y
3.2
Industry
5.3
vs History
32
vs Industry
49
Median 3Y
3.5
Median 5Y
3
Industry
12.8
Forward
4.1
vs History
vs Industry
3
Median 3Y
40.1
Median 5Y
39.8
Industry
16.2
Forward
-6
vs History
62
vs Industry
52
Median 3Y
5
Median 5Y
5
Industry
15.1
vs History
2
vs Industry
25
Median 3Y
-8.5
Median 5Y
-8.5
Industry
17.7
vs History
77
vs Industry
82
Median 3Y
0.4
Median 5Y
0.4
Industry
1.9

Multiples Across Competitors

EAPI Competitors Multiples
Euroapi SAS Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Euroapi SAS
PAR:EAPI
306.6m EUR 0.3 -2.3 4.4 -35
US
Eli Lilly and Co
NYSE:LLY
751.2B USD 15.4 67.8 36.3 39.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
381.4B USD 4.3 17.5 12.8 16.8
DK
Novo Nordisk A/S
CSE:NOVO B
2T DKK 6.6 19.2 13.3 15.2
CH
Roche Holding AG
SIX:ROG
208.2B CHF 3.4 25.2 9.4 11.1
CH
Novartis AG
SIX:NOVN
194.7B CHF 4.6 19.1 11.2 15
UK
AstraZeneca PLC
LSE:AZN
164.9B GBP 4.1 28.8 131 197.6
US
Merck & Co Inc
NYSE:MRK
212.8B USD 3.3 12.2 9 11
IE
Endo International PLC
LSE:0Y5F
184.8B USD 79.7 -63.2 294 737.3
US
Pfizer Inc
NYSE:PFE
147.8B USD 2.4 18.7 7.9 11.1
P/E Multiple
Earnings Growth PEG
FR
E
Euroapi SAS
PAR:EAPI
Average P/E: 26.1
Negative Multiple: -2.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
67.8
49%
1.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
17.5
27%
0.6
DK
Novo Nordisk A/S
CSE:NOVO B
19.2
18%
1.1
CH
Roche Holding AG
SIX:ROG
25.2
32%
0.8
CH
Novartis AG
SIX:NOVN
19.1
17%
1.1
UK
AstraZeneca PLC
LSE:AZN
28.8
36%
0.8
US
Merck & Co Inc
NYSE:MRK
12.2
17%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -63.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
18.7
30%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
E
Euroapi SAS
PAR:EAPI
Average EV/EBITDA: 397.8
4.4
22%
0.2
US
Eli Lilly and Co
NYSE:LLY
36.3
30%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
12.8
7%
1.8
DK
Novo Nordisk A/S
CSE:NOVO B
13.3
13%
1
CH
Roche Holding AG
SIX:ROG
9.4
5%
1.9
CH
Novartis AG
SIX:NOVN
11.2
5%
2.2
UK
AstraZeneca PLC
LSE:AZN
131
10%
13.1
US
Merck & Co Inc
NYSE:MRK
9
8%
1.1
IE
E
Endo International PLC
LSE:0Y5F
294
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.9
2%
4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
E
Euroapi SAS
PAR:EAPI
Average EV/EBIT: 1 875.7
Negative Multiple: -35
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.7
32%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
16.8
13%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
15.2
14%
1.1
CH
Roche Holding AG
SIX:ROG
11.1
6%
1.8
CH
Novartis AG
SIX:NOVN
15
10%
1.5
UK
AstraZeneca PLC
LSE:AZN
197.6
23%
8.6
US
Merck & Co Inc
NYSE:MRK
11
11%
1
IE
E
Endo International PLC
LSE:0Y5F
737.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
11.1
10%
1.1